✦ LIBER ✦

Human visceral adipose tissue and the plasminogen activator inhibitor type 1

✍ Scribed by Lindeman, J H N; Pijl, H; Toet, K; Eilers, P H C; van Ramshorst, B; Buijs, M M; van Bockel, J H; Kooistra, T

Book ID: 110046206
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 172 KB
Volume: 31
Category: Article
ISSN: 1476-5497
DOI: 10.1038/sj.ijo.0803650

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased plasminogen activator inhibito

Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis

✍ S-F Yang; Y-S Hsieh; C-H Tsai; Y-J Chen; Y-C Chang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

Postoperative changes in plasma tissue-t

Postoperative changes in plasma tissue-type plasminogen activator and type I plasminogen activator inhibitor

✍ Katsunori Aoki; Nobuhiko Nishino; Shozo Baba; Tetsumei Urano; Akikazu Takada 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 400 KB

Plasminogen activator inhibitor type 1 d

Plasminogen activator inhibitor type 1 deficiency

✍ R. MEHTA; A. D. SHAPIRO 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Circulating tissue-type plasminogen acti

Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study

✍ A.J. Simpson; N.A. Booth; N.R. Moore; S.J. Lewis; R.S. Gray 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 45 KB

Immunohistochemical localization of tiss

Immunohistochemical localization of tissue-type plasminogen activator and type I plasminogen activator inhibitor in radicular cysts

✍ Chung-Hung Tsai; Sheng-Feng Weng; Li-Chiu Yang; Fu-Mei Huang; Yi-Juai Chen; Yu-C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR I

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN RENAL CELL CARCINOMA

✍ WAGNER, STEPHAN N.; ATKINSON, MICHAEL J.; THANNER, STEPHANIE; SCHMITT, MANFRED; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

In experimental models, plasminogen activator-mediated degradation of the extracellular matrix is inhibited by type-1 plasminogen activator inhibitor (PAI-1). PA14 has also been shown to protect tumour stromal tissue from autoproteolytic activities and may thus substantially promote tumour growth an